These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24378710)

  • 1. Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.
    González-Naranjo P; Pérez-Macias N; Campillo NE; Pérez C; Arán VJ; Girón R; Sánchez-Robles E; Martín MI; Gómez-Cañas M; García-Arencibia M; Fernández-Ruiz J; Páez JA
    Eur J Med Chem; 2014 Feb; 73():56-72. PubMed ID: 24378710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indazolylketones as new multitarget cannabinoid drugs.
    González-Naranjo P; Pérez-Macias N; Pérez C; Roca C; Vaca G; Girón R; Sánchez-Robles E; Martín-Fontelles MI; de Ceballos ML; Martin-Requero A; Campillo NE; Páez JA
    Eur J Med Chem; 2019 Mar; 166():90-107. PubMed ID: 30685536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for new multi-target compounds against Alzheimer's disease among histamine H
    Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
    Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
    Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.
    Li Y; Peng P; Tang L; Hu Y; Hu Y; Sheng R
    Bioorg Med Chem; 2014 Sep; 22(17):4717-25. PubMed ID: 25082512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cannabinoid receptor antagonists as pharmacological tool.
    González-Naranjo P; Pérez C; Girón R; Sánchez-Robles EM; Martín-Fontelles MI; Carrillo-López N; Martín-Vírgala J; Naves M; Campillo NE; Páez JA
    Bioorg Med Chem; 2020 Oct; 28(19):115672. PubMed ID: 32912440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitarget drugs as potential therapeutic agents for alzheimer's disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors.
    González-Naranjo P; Pérez C; González-Sánchez M; Gironda-Martínez A; Ulzurrun E; Bartolomé F; Rubio-Fernández M; Martin-Requero A; Campillo NE; Páez JA
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2348-2356. PubMed ID: 36050834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT
    Marcinkowska M; Bucki A; Panek D; Siwek A; Fajkis N; Bednarski M; Zygmunt M; Godyń J; Del Rio Valdivieso A; Kotańska M; Kołaczkowski M; Więckowska A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900041. PubMed ID: 31162703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
    Yrjölä S; Sarparanta M; Airaksinen AJ; Hytti M; Kauppinen A; Pasonen-Seppänen S; Adinolfi B; Nieri P; Manera C; Keinänen O; Poso A; Nevalainen TJ; Parkkari T
    Eur J Pharm Sci; 2015 Jan; 67():85-96. PubMed ID: 25447744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease.
    Sánchez Montero JM; Agis-Torres A; Solano D; Söllhuber M; Fernandez M; Villaro W; Gómez-Cañas M; García-Arencibia M; Fernández-Ruiz J; Egea J; Martín MI; Girón R
    Eur J Pharmacol; 2021 Mar; 895():173875. PubMed ID: 33460612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
    Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P
    Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
    Feng B; Li X; Xia J; Wu S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
    Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
    Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and SAR Studies of Heteroarylpyrimidines and Heteroaryltriazines as CB
    Qian HY; Wang ZL; Chen LL; Pan YL; Xie XY; Xie X; Chen JZ
    ChemMedChem; 2018 Nov; 13(22):2455-2463. PubMed ID: 30246417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological activity of 1H-indene-2-carboxamides as multi-targeted anti-Alzheimer agents.
    Koca M; Yerdelen KO; Anil B; Kasap Z; Sevindik H; Ozyurek I; Gunesacar G; Turkaydin K
    J Enzyme Inhib Med Chem; 2016; 31(sup2):13-23. PubMed ID: 27226239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.